India to Australia: Betadine Export Trade Route

The India to Australia Betadine corridor is one of India's established pharmaceutical export routes, with 49 shipments documented worth a combined $1.4M USD. The route is dominated by MAPAEX CONSUMER HEALTHCARE PRIVATE LIMITED , which alone accounts for roughly 55% of all export value, reflecting the consolidated nature of India's betadine manufacturing sector.

Across 7 active suppliers, the average shipment value stands at $29.3K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 80% of all shipments, consistent with betadine's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 32 days port-to-port. The route has recorded an annual growth rate of 29.2%, placing it at rank #9 among India's top betadine export destinations globally.

On the import side, key buyers of Indian betadine in Australia include Nova Pharmaceuticals Australasia Pt , Nova Pharmaceuticals Australasia Pt, NOVA PHARMACEUTICALS AUSTRALASIA PT and 3 others. Nova Pharmaceuticals Australasia Pt is the single largest importer with 23 shipments valued at $913.3K USD.

India's betadine exports to Australia are driven primarily by a handful of large-scale manufacturers. MAPAEX CONSUMER HEALTHCARE PRIVATE LIMITED with 18 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 7 active exporters signals a competitive but concentrated market — buyers in Australia benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — MAPAEX CONSUMER HEALTHCARE PRIVATE LIMITED , MAPAEX CONSUMER HEALTHCARE PRIVATE LIMITED, MAKSON HEALTH CARE PRIVATE LIMITED — together account for 88% of total trade value on this route. The average shipment value of $29.3K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as anaesthetic lozenges - betadine anaesthe and anaesthetic lozenges betadine anaesthe, suggesting that buyers in Australia tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, Nova Pharmaceuticals Australasia Pt is the largest importer with 23 shipments worth $913.3K USD — representing 64% of all betadine imports from India on this route. A total of 6 buyers are active on this corridor.